Mitochondrial Dysfunction due to Novel COQ8A Variation with Poor Response to CoQ10 Treatment: A Comprehensive Study and Review of Literatures
- 2 March 2024
- journal article
- research article
- Published by Springer Nature in The Cerebellum
- Vol. 23 (5) , 1824-1838
Abstract
COQ8A plays an important role in the biosynthesis of coenzyme Q10 (CoQ10), and variations in COQ8A gene are associated with primary CoQ10 deficiency-4 (COQ10D4), also known as COQ8A-ataxia. The current understanding of the association between the specific variant type, the severity of CoQ10 deficiency, and the degree of oxidative stress in individuals with primary CoQ10 deficiencies remains uncertain. Here we provide a comprehensive analysis of the clinical and genetic characteristics of an 18-year-old patient with COQ8A-ataxia, who exhibited novel compound heterozygous variants (c.1904_1906del and c.637C > T) in the COQ8A gene. These variants reduced the expression levels of COQ8A and mitochondrial proteins in the patient’s muscle and skin fibroblast samples, contributed to mitochondrial respiration deficiency, increased ROS production and altered mitochondrial membrane potential. It is worth noting that the optimal treatment for COQ8A-ataxia remains uncertain. Presently, therapy consists of CoQ10 supplementation, however, it did not yield significant improvement in our patient's symptoms. Additionally, we reviewed the response of CoQ10 supplementation and evolution of patients in previous literatures in detail. We found that only half of patients could got notable improvement in ataxia. This research aims to expand the genotype–phenotype spectrum of COQ10D4, address discrepancies in previous reviews regarding the effectiveness of CoQ10 in these disorders, and help to establish a standardized treatment protocol for COQ8A-ataxia.Keywords
Funding Information
- The National Natural Science Foundation of China (No.82301590, No.82071412, No.82171394)
- China Postdoctoral Science Foundation (2023M742116)
- Natural Science Foundation of Shandong Province (ZR2023QH106)
- Shandong Provincial Postdoctoral Innovation Talent Support Program (SDBX2022061)
- Grants from the National Key R&D Program of China (No.2021YFC2700904)
- People's benefit project of science and technology in Qingdao (20-3-4-42-nsh)
- the Taishan Scholars Program of Shandong Province
This publication has 40 references indexed in Scilit:
- Primary coenzyme Q10 deficiency due to COQ8A gene mutationsMolecular Genetics & Genomic Medicine, 2020
- Early‐onset coenzyme Q10 deficiency associated with ataxia and respiratory chain dysfunction due to novel pathogenic COQ8A variants, including a large intragenic deletionJIMD Reports, 2020
- Clinico‐Genetic, Imaging and Molecular Delineation of COQ8A‐Ataxia: A Multicenter Study of 59 PatientsAnnals of Neurology, 2020
- Primary Coenzyme Q deficiency Due to Novel ADCK3 Variants, Studies in Fibroblasts and Review of LiteratureNeurochemical Research, 2019
- ADCK3‐related Coenzyme Q10 Deficiency: A Potentially Treatable Genetic DiseaseMovement Disorders Clinical Practice, 2018
- Efficacy of Exome-Targeted Capture Sequencing to Detect Mutations in Known Cerebellar Ataxia GenesJAMA Neurology, 2018
- Compound Heterozygous Inheritance of Mutations in Coenzyme Q8A Results in Autosomal Recessive Cerebellar Ataxia and Coenzyme Q10 Deficiency in a Female Sib-Pair2017
- Novel Mitochondrial C15620A Variant may Modulate the Phenotype of Mitochondrial G11778A Mutation in a Chinese Family with Leigh SyndromeNeuroMolecular Medicine, 2013
- Heterozygous Mutations in the ADCK3 Gene in Siblings with Cerebellar Atrophy and Extreme Phenotypic Variability2013
- Human CoQ10 deficienciesBioFactors, 2008